Mar 13, 2025 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the Zomedica fourth quarter 2024 financial results conference call. (Operator Instructions) This call is being recorded on Thursday, March 13, 2025. I would now like to turn the conference over to Mr. Mike Vallie from ICR. Please go ahead.
Michael Vallie - ICR - Investor Relations
Thank you, operator, and good afternoon, ladies and gentlemen. Welcome to Zomedica's fourth quarter 2024 earnings results and business update call. Joining me on today's call are Zomedica's Chief Executive Officer, Larry Heaton; Scott Jordan, the company's new Executive Vice President and Chief Financial Officer; and Mike Zuehlke, Vice President and Corporate Controller. Before we begin, we would like to remind everyone that on this call, we will be making various remarks about future expectations, plans and prospects that constitute forward-looking statements. These forward-looking statements are based on assumptions, and there are risks that the results may differ materially from those statements.
As such, Zomedica cannot
Q4 2024 Zomedica Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
